{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:25:06Z","timestamp":1782962706266,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"DOI":"10.1186\/s13044-026-00291-w","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T08:21:29Z","timestamp":1772007689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Iodide for the management of Graves\u2019 disease in pregnancy"],"prefix":"10.1186","volume":"19","author":[{"given":"Ai","family":"Yoshihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeduk Yoshimura","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"issue":"4","key":"291_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000490384","volume":"7","author":"GJ Kahaly","year":"2018","unstructured":"Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, Pearce SH. 2018 European Thyroid Association Guideline for the Management of Graves\u2019 Hyperthyroidism. Eur thyroid J. 2018;7(4):167\u201386.","journal-title":"Eur thyroid J"},{"issue":"3","key":"291_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/thy.2016.0457","volume":"27","author":"EK Alexander","year":"2017","unstructured":"Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315\u201389.","journal-title":"Thyroid"},{"key":"291_CR3","unstructured":"JTA. Guideline for the Treatment of Graves\u2019Disease in Japan 2019. Nankodo; 2019."},{"issue":"6","key":"291_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.7326\/M17-1398","volume":"168","author":"GH Seo","year":"2018","unstructured":"Seo GH, Kim TH, Chung JH. Antithyroid Drugs and Congenital Malformations: A Nationwide Korean Cohort Study. Ann Intern Med. 2018;168(6):405\u201313.","journal-title":"Ann Intern Med"},{"issue":"11","key":"291_CR5","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1210\/jc.2013-2831","volume":"98","author":"SL Andersen","year":"2013","unstructured":"Andersen SL, Olsen J, Wu CS, Laurberg P. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocrinol Metab. 2013;98(11):4373\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"291_CR6","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1089\/thy.2022.0088","volume":"32","author":"X Hou","year":"2022","unstructured":"Hou X, Guan H, Sun S, Shi Y, Li C, Liu A, et al. Outcomes of Early-Pregnancy Antithyroid Drug Withdrawal in Graves\u2019 Disease: A Preliminary Prospective Follow-Up Study. Thyroid. 2022;32(8):983\u20139.","journal-title":"Thyroid"},{"key":"291_CR7","first-page":"1955","volume":"80","author":"HS Plummer","year":"1923","unstructured":"Plummer HS. Results of administering iodine to patients having exophthalmic goiter. JAMA. 1923;80:1955.","journal-title":"JAMA"},{"issue":"1","key":"291_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1210\/jcem-40-1-33","volume":"40","author":"CH Emerson","year":"1975","unstructured":"Emerson CH, Anderson AJ, Howard WJ, Utiger RD. Serum thyroxine and triiodothyronine concentrations during iodide treatment of hyperthyroidism. J Clin Endocrinol Metab. 1975;40(1):33\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"291_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/archinte.1930.00140100003001","volume":"45","author":"WO THOMPSON","year":"1930","unstructured":"THOMPSON WO, THOMPSON PK, BRAILEY AG, COHEN AC. PROLONGED TREATMENT OF EXOPHTHALMIC GOITER BY IODINE ALONE. Arch Intern Med. 1930;45(4):481\u2013502.","journal-title":"Arch Intern Med"},{"issue":"3","key":"291_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/archinte.1931.00150030002001","volume":"48","author":"WO THOMPSON","year":"1931","unstructured":"THOMPSON WO, THOMPSON PK. EXOPHTHALMIC GOITER: THE DEVELOPMENT OF REFRACTORINESS TO IODINE. Arch Intern Med. 1931;48(3):351\u201376.","journal-title":"Arch Intern Med"},{"issue":"2","key":"291_CR11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0021-9258(18)57335-X","volume":"174","author":"J Wolff","year":"1948","unstructured":"Wolff J, Chaikoff IL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem. 1948;174(2):555\u201364.","journal-title":"J Biol Chem"},{"issue":"4","key":"291_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1210\/jcem-30-4-469","volume":"30","author":"S Nagataki","year":"1970","unstructured":"Nagataki S, Shizume K, Nakao K. Effect of iodide on thyroidal iodine turnover in hyperthyroid subjects. J Clin Endocrinol Metab. 1970;30(4):469\u201378.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"291_CR13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1089\/thy.2022.0496","volume":"33","author":"T Uchida","year":"2023","unstructured":"Uchida T, Shimamura M, Taka H, Kaga N, Miura Y, Nishida Y, et al. The Effect of Long-Term Inorganic Iodine on Intrathyroidal Iodothyronine Content and Gene Expression in Mice with Graves\u2019 Hyperthyroidism. Thyroid. 2023;33(3):330\u20137.","journal-title":"Thyroid"},{"issue":"3","key":"291_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/thy.2023.0068","volume":"33","author":"PA Kopp","year":"2023","unstructured":"Kopp PA. Iodine in the Therapy of Graves\u2019 Disease: A Century After Henry S. Plummer Thyroid. 2023;33(3):273\u20135.","journal-title":"Plummer Thyroid"},{"key":"291_CR15","doi-asserted-by":"crossref","unstructured":"Okamura K, Sato K, Fujikawa M, Bandai S, Ikenoue H, Kitazono T. Remission after potassium iodide therapy in patients with Graves\u2019 hyperthyroidism exhibiting thionamide-associated side effects. J Clin Endocrinol Metab. 2014:jc20134466.","DOI":"10.1210\/jc.2013-4466"},{"issue":"8","key":"291_CR16","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1507\/endocrj.EJ21-0436","volume":"69","author":"K Okamura","year":"2022","unstructured":"Okamura K, Sato K, Fujikawa M, Bandai S, Ikenoue H, Kitazono T. Iodide-sensitive Graves\u2019 hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment. Endocr J. 2022;69(8):983\u201397.","journal-title":"Endocr J"},{"key":"291_CR17","doi-asserted-by":"crossref","unstructured":"Suzuki N, Yoshimura Noh J, Sugisawa C, Hoshiyama A, Hiruma M, Kawaguchi A, et al. Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves\u2019 disease. Endocr J. 2020.","DOI":"10.1507\/endocrj.EJ19-0379"},{"issue":"6","key":"291_CR18","doi-asserted-by":"publisher","first-page":"e240085","DOI":"10.1530\/ETJ-24-0085","volume":"13","author":"M Fujikawa","year":"2024","unstructured":"Fujikawa M, Okamura K. Graves\u2019 hyperthyroidism treated with potassium iodide: early response and after 2 years of follow-up. Eur thyroid J. 2024;13(6):e240085.","journal-title":"Eur thyroid J"},{"issue":"2","key":"291_CR19","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s12020-014-0171-8","volume":"47","author":"T Uchida","year":"2014","unstructured":"Uchida T, Goto H, Kasai T, Komiya K, Takeno K, Abe H, et al. Therapeutic effectiveness of potassium iodine in drug-naive patients with Graves\u2019 disease: a single-center experience. Endocrine. 2014;47(2):506\u201311.","journal-title":"Endocrine"},{"issue":"3","key":"291_CR20","first-page":"738","volume":"75","author":"N Momotani","year":"1992","unstructured":"Momotani N, Hisaoka T, Noh J, Ishikawa N, Ito K. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves\u2019 disease complicated by pregnancy. J Clin Endocrinol Metab. 1992;75(3):738\u201344.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"291_CR21","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1089\/thy.2014.0581","volume":"25","author":"A Yoshihara","year":"2015","unstructured":"Yoshihara A, Noh JY, Watanabe N, Mukasa K, Ohye H, Suzuki M, et al. Substituting Potassium Iodide for Methimazole as the Treatment for Graves\u2019 Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan. Thyroid. 2015;25(10):1155\u201361.","journal-title":"Thyroid"},{"issue":"3","key":"291_CR22","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1089\/thy.2019.0392","volume":"30","author":"A Yoshihara","year":"2020","unstructured":"Yoshihara A, Noh JY, Watanabe N, Kunii Y, Suzuki M, Matsumoto M, et al. Characteristics of Patients with Graves\u2019 Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy. Thyroid. 2020;30(3):451\u20136.","journal-title":"Thyroid"},{"issue":"12","key":"291_CR23","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1089\/thy.2004.14.1077","volume":"14","author":"S Nishiyama","year":"2004","unstructured":"Nishiyama S, Mikeda T, Okada T, Nakamura K, Kotani T, Hishinuma A. Transient hypothyroidism or persistent hyperthyrotropinemia in neonates born to mothers with excessive iodine intake. Thyroid. 2004;14(12):1077\u201383.","journal-title":"Thyroid"},{"issue":"2","key":"291_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/BF03343825","volume":"24","author":"L Bartalena","year":"2001","unstructured":"Bartalena L, Bogazzi F, Braverman LE, Martino E. Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest. 2001;24(2):116\u201330.","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"291_CR25","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1111\/j.1651-2227.2009.01412.x","volume":"98","author":"A Ahmet","year":"2009","unstructured":"Ahmet A, Lawson ML, Babyn P, Tricco AC. Hypothyroidism in neonates post-iodinated contrast media: a systematic review. Acta Paediatr. 2009;98(10):1568\u201374.","journal-title":"Acta Paediatr"},{"key":"291_CR26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.neuroscience.2019.02.016","volume":"406","author":"D Lebsir","year":"2019","unstructured":"Lebsir D, Guemri J, Kereselidze D, Grison S, Benderitter M, Pech A, et al. Repeated potassium iodide exposure during pregnancy impairs progeny\u2019s brain development. Neuroscience. 2019;406:606\u201316.","journal-title":"Neuroscience"}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-026-00291-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13044-026-00291-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-026-00291-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T08:21:34Z","timestamp":1772007694000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13044-026-00291-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["291"],"URL":"https:\/\/doi.org\/10.1186\/s13044-026-00291-w","relation":{},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}